Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Clearpoint Neuro Inc
(NQ:
CLPT
)
11.88
+0.51 (+4.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clearpoint Neuro Inc
< Previous
1
2
3
Next >
Earnings Scheduled For August 10, 2021
August 10, 2021
Companies Reporting Before The Bell • Nautilus Biotechnology (NASDAQ:NAUT) is expected to report earnings for its second quarter. • Fulcrum Therapeutics (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
August 08, 2021
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 22, 2021
Gainers Tenax Therapeutics (NASDAQ:TENX) ...
Via
Benzinga
ClearPoint Neuro: Return On Capital Employed Insights
June 18, 2021
ClearPoint Neuro (NASDAQ:CLPT) reported Q1 sales of $4.03 million. Earnings fell to a loss of $2.18 million, resulting in a 3.72% decrease from last quarter. In Q4, ClearPoint...
Via
Benzinga
ClearPoint Neuro Insights: Return On Capital Employed
June 03, 2021
During Q1, ClearPoint Neuro (NASDAQ:CLPT) brought in sales totaling $4.03 million. However, earnings decreased 3.72%, resulting in a loss of $2.18 million. ClearPoint Neuro...
Via
Benzinga
MedTech Round Up: Update On Lucira Health, Second Sight Medical ClearPoint Neuro, Medtronic, Sientra
May 12, 2021
Lucira Health Inc (NASDAQ: LHDX) has announced that its Lucira Check IT COVID-19 test kit is now available on Amazon.com in the US. Each Lucira Check IT test...
Via
Benzinga
Exposures
COVID-19
Earnings Scheduled For May 11, 2021
May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is...
Via
Benzinga
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron
May 12, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 12, 2021
Gainers Second Sight Medical (NASDAQ:EYES) shares increased by 25.39% to $6.27 during Wednesday's pre-market session. The company's market cap stands at $174.9...
Via
Benzinga
ClearPoint Neuro, Inc. (CLPT) Q1 2021 Earnings Call Transcript
May 12, 2021
CLPT earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
ClearPoint Neuro: Q1 Earnings Insights
May 11, 2021
Shares of ClearPoint Neuro (NASDAQ:CLPT) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 0.00% over...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
May 11, 2021
Gainers Minerva Neurosciences (NASDAQ:NERV
Via
Benzinga
How Jonah Lupton Expects TransMedics Group Stock To React To FDA Decision
April 06, 2021
Jonah Lupton of Lupton Capital was focused on TransMedics Group Inc (NASDAQ: TMDX) Tuesday. The Nasdaq halted trading in TransMedics stock while the FDA...
Via
Benzinga
Exposures
Product Safety
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
May 11, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -...
Via
Benzinga
Exposures
COVID-19
Product Safety
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings
May 09, 2021
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came...
Via
Benzinga
Exposures
COVID-19
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.